Wells Fargo & Company Glaukos Corp Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
A detailed history of Wells Fargo & Company transactions in Glaukos Corp stock. As of the latest transaction made, Wells Fargo & Company holds 32,512 shares of GKOS stock, worth $3.14 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,512
Previous 25,120
29.43%
Holding current value
$3.14 Million
Previous $3.27 Million
48.96%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding GKOS
# of Institutions
355Shares Held
50.1MCall Options Held
282KPut Options Held
401K-
Black Rock Inc. New York, NY8.04MShares$777 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$578 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA2.16MShares$209 Million0.06% of portfolio
-
State Street Corp Boston, MA2.06MShares$199 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.93MShares$187 Million0.08% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.6B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...